| Fecal Microbiota Transplant for Treatment ofClostridium difficileInfection in Immunocompromised Patients CR Kelly, C Ihunnah, M Fischer, A Khoruts, C Surawicz, A Afzali, ... Official journal of the American College of Gastroenterology| ACG 109 (7 …, 2014 | 724 | 2014 |
| Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP) M You, M Fischer, MA Deeg, DW Crabb Journal of Biological Chemistry 277 (32), 29342-29347, 2002 | 597 | 2002 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 378 | 2019 |
| ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections CR Kelly, M Fischer, JR Allegretti, K LaPlante, DB Stewart, BN Limketkai, ... Official journal of the American College of Gastroenterology| ACG 116 (6 …, 2021 | 327 | 2021 |
| Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice M Fischer, M You, M Matsumoto, DW Crabb Journal of Biological Chemistry 278 (30), 27997-28004, 2003 | 325 | 2003 |
| The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications JR Allegretti, BH Mullish, C Kelly, M Fischer The Lancet 394 (10196), 420-431, 2019 | 287 | 2019 |
| The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor α is inhibited by ethanol metabolism: a novel mechanism for the development of … A Galli, J Pinaire, M Fischer, R Dorris, DW Crabb Journal of Biological Chemistry 276 (1), 68-75, 2001 | 274 | 2001 |
| Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha DW Crabb, A Galli, M Fischer, M You Alcohol 34 (1), 35-38, 2004 | 196 | 2004 |
| Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach M Fischer, B Sipe, YW Cheng, E Phelps, N Rogers, S Sagi, M Bohm, H Xu, ... Gut microbes 8 (3), 289-302, 2017 | 192 | 2017 |
| Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease M Fischer, D Kao, C Kelly, A Kuchipudi, SM Jafri, M Blumenkehl, D Rex, ... Inflammatory bowel diseases 22 (10), 2402-2409, 2016 | 177 | 2016 |
| A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn’s disease JD Lewis, RS Sandler, C Brotherton, C Brensinger, H Li, MD Kappelman, ... Gastroenterology 161 (3), 837-852. e9, 2021 | 174 | 2021 |
| Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel G Ianiro, BH Mullish, CR Kelly, H Sokol, Z Kassam, SC Ng, M Fischer, ... The lancet Gastroenterology & hepatology 5 (5), 430-432, 2020 | 158 | 2020 |
| Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry CR Kelly, EF Yen, AM Grinspan, SA Kahn, A Atreja, JD Lewis, TA Moore, ... Gastroenterology 160 (1), 183-192. e3, 2021 | 143 | 2021 |
| Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020 | 142 | 2020 |
| Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium difficile infection: a multicenter study M Fischer, D Kao, SR Mehta, T Martin, J Dimitry, AH Keshteli, GK Cook, ... Official journal of the American College of Gastroenterology| ACG 111 (7 …, 2016 | 142 | 2016 |
| Open: Vedolizumab for ulcerative colitis: treatment outcomes from the VICTORY consortium N Narula, F Peerani, J Meserve, G Kochhar, K Chaudrey, J Hartke, ... Official journal of the American College of Gastroenterology| ACG 113 (9), 1345, 2018 | 141 | 2018 |
| The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis T Qazi, T Amaratunga, EL Barnes, M Fischer, Z Kassam, JR Allegretti Gut microbes 8 (6), 574-588, 2017 | 126 | 2017 |
| Donor screening for fecal microbiota transplantation Z Kassam, N Dubois, B Ramakrishna, K Ling, T Qazi, M Smith, CR Kelly, ... New England Journal of Medicine 381 (21), 2070-2072, 2019 | 120 | 2019 |
| Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: a multicenter experience YW Cheng, E Phelps, V Ganapini, N Khan, F Ouyang, H Xu, S Khanna, ... American journal of transplantation 19 (2), 501-511, 2019 | 116 | 2019 |
| Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis H Herfarth, EL Barnes, JF Valentine, J Hanson, PDR Higgins, KL Isaacs, ... Gastroenterology 155 (4), 1098-1108. e9, 2018 | 84 | 2018 |
